The Key To Painless Data Integrity For Bioanalysis Labs

Data integrity warning letters increased from 47% in 2019 to 51% in 2020, to 65% in 2021. While some industry insiders attribute the rise simply to greater scrutiny, one cannot ignore that issues do exist. Pharmaceutical sponsors rate data quality and data integrity as one of their greatest concerns when outsourcing to a CRO. Generating high-quality data for informed, real-time insight and reporting while also supporting regulatory and operational considerations will set a CRO apart in the highly competitive outsourcing landscape.

While the CRO industry is tremendously efficient in generating data, there remains a breakdown in efficiency when it comes to reviewing and tracking data for quality and compliance. Learn more about the opportunities to address these inefficiencies and others related to data management.